GNRH1 and ovarian carcinoma: In vivo studies in ovarian carcinoma resistant to platinum chemotherapy showed that the use of both GnRH analogs and chemotherapy produces cytotoxic effects in ovarian cancer xenografts, with a significant reduction in the volume of ovarian tumors (14, 69).